Alternatives to Quince Therapeutics
Quince Therapeutics is a Biotechnology tool: a biopharmaceutical company focused on developing novel therapies. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Quince Therapeutics
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website LŌLōkahi Therapeutics57BiotechnologyLa Jolla, USA$63.0M
A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
Anagram Therapeutics55BiotechnologyNatick, USA$285.0MClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
- Website
Verdiva Bio54BiotechnologySan Diego, United States$170.0MClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
- Website
TG Therapeutics49BiotechnologyNew York, USA$360.0MA commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.
- Website
Adaptimmune Therapeutics44BiotechnologyAbingdon, United Kingdom$107.5MBiopharmaceutical company developing T-cell therapies for solid tumor cancers.
- Website
ONCOMATRYX50BiotechnologyDerio, Spain$106.8MDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
- Website
Lysoway Therapeutics48BiotechnologyCambridge, USA$45.0MDeveloping small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.
- Website
DiaMedica Therapeutics35BiotechnologyMinneapolis, United States$30.1MClinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases.
- Website GEGenexine47BiotechnologySeoul, South Korea$296.5M
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
- Website
Adocia46BiotechnologyLyon, FranceA clinical-stage biopharmaceutical company focused on innovative therapeutic solutions for diabetes and obesity.
- Website
argenx49BiTechAmsterdam, Netherlands$51.1MGlobal immunology company developing antibody-based therapies for severe autoimmune diseases.
- Website
Axsome Therapeutics9BiotechNew York, United StatesBiopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- JUJuno Therapeutics66BiotechnologySeattle, United States$316.7M
Biotechnology company focused on developing cancer immunotherapies.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
Seaport Therapeutics62BiotechnologyCambridge, USA$340.0MDeveloping novel therapeutics to restore gut lymphatic function.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Showing the 20 closest matches. See the rest on the Quince Therapeutics profile.
Compare Quince Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.